Vaginitis and vaginosis are responsible for over 10 million visits per year to physician offices by women in the U.S. In this podcast, Repertoire publisher Scott Adams speaks to Cisco Merrill, national sales director, alternate site for Cepheid about the molecular diagnostic company’s entry into the sexual health market with its Xpert® Xpress MVP test.
The Xpert Xpress MVP test is an on-demand PCR test that is FDA cleared and aids clinicians in diagnosing three distinct sexually transmitted infections (STIs) – bacterial vaginosis (BV), Candida species associated with vulvovaginal candidiasis and trichomoniasis – that cause overlapping symptoms and potential co-occurrence.
The ability to test in house and treat in one visit is powerful for primary care, OB-GYN and urgent care physicians and their patients.